GlassScriptPhysician profile
Pierre A Caron
NPI 1871588947
$1,282.37
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $307 · 2021: $345 · 2022: $280 · 2023: $90.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $302.66 | 2019-2022 | |
| Amgen INC. | $187.94 | 2020-2021 | |
| Novo Nordisk INC | $174.13 | 2019-2022 | |
| Lilly USA, LLC | $140.51 | 2020-2021 | |
| Pfizer INC. | $113.91 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.79 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $42.80 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $41.98 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $39.35 | 2019-2022 | |
| Exact Sciences Corporation | $25.30 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $24.28 | 2022 | |
| Celgene Corporation | $21.75 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.19 | 2019 | |
| Amarin Pharma, INC. | $17.37 | 2019 | |
| Allergan, INC. | $17.29 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.87 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.65 | 2022 | |
| Alkermes, INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Caron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.